Clinical Trial Update: Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating udenafil for erectile dysfunction and benign prostatic hyperplasia has been withdrawn. No further development details provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Erectile Dysfunction

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Takeda | Conditions: Erectile Dysfunction, Benign Prostatic Hyperplasia | Phase 2 | Status: WITHDRAWN